Alisa Pedrana is public health practitioner and senior research fellow at Burnet Institute. Her research career has focussed on Blood-borne virus/Sexually Transmitted Infections epidemiology and surveillance to inform prevention practice and policy. With a strong emphasis on research translation, her current work on Hepatitis C elimination is focussed on implementation science to strengthen health systems, enhance health service delivery and develop sustainable models of care.

Phillip is the Director of the Kirketon Road Centre, a primary health care facility in Kings Cross, Sydney.

Joseph Doyle is an infectious diseases physician at The Alfred in Melbourne.

Dr Dean Murphy works in the Department of Gender and Cultural Studies at University of Sydney, undertaking research on experiences of drug use among sexual and gender minorities; and also works at the Kirby Institute, UNSW. He has published widely on biomedical prevention, HIV and BBVs, sexuality, gender, and kinship.

Brendan works as a data analyst and research assistant on hepatitis C related projects among people living with HIV and people who inject drugs. He is also currently completing a Master of Public Health at Monash University.

Dr Lafferty is a research fellow at the Centre for Social Research in Health, UNSW Sydney. Her research focuses on the social and behavioural components underpinning hepatitis C risk, prevention, transmission, testing, treatment, and reinfection in the prison setting.

Behzad Hajari is a clinical epidemiologist, a Senior Lecturer in the Kirby Institute (UNSW Sydney) and an NHMRC fellow. He trained as a Medical Practitioner and has an MPH and PhD in Medicine. His research interests include HCV care in prison setting and among people who inject drugs.

Stephen is Deputy CEO, Penington Institute and has worked in the area of blood borne viruses and harm reduction for over twenty years in research and policy.

Sinead is employed by Royal Prince Alfred Hospital Sydney, in a hospital-led, community-based Hepatology Nurse Practitioner role, focused mainly in Drug Health settings with a strong HCV elimination focus. She is committed to identifying and addressing barriers to HCV care for marginalised populations and improving hepatitis care in community settings.

Evan is a postdoctoral fellow in the Viral Hepatitis Clinical research Program at the Kirby Institute in Sydney, Australia. His research is focused on the treatment of HCV infection in high risk populations including people who inject drugs and prisoners.